Durvalumab with or Without Tremelimumab for Patients with Metastatic Pancreatic Ductal Adenocarcinoma: A Phase 2 Randomized Clinical Trial

Eileen M. O'Reilly, Do Youn Oh, Neesha Dhani, Daniel J. Renouf, Myung Ah Lee, Weijing Sun, George Fisher, Aram Hezel, Shao Chun Chang, Gordana Vlahovic, Osamu Takahashi, Yin Yang, David Fitts, Philip Agop Philip

Research output: Contribution to journal › Article › peer-review

526 Scopus citations

Fingerprint

Dive into the research topics of 'Durvalumab with or Without Tremelimumab for Patients with Metastatic Pancreatic Ductal Adenocarcinoma: A Phase 2 Randomized Clinical Trial'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science